Release Date: November 24, 2025
Expiration Date: November 24, 2026
Activity Overview
This on-demand virtual symposium brings together expert clinician-researchers to discuss the role of B-cell pathways in the pathophysiology of generalized myasthenia gravis and how this provides therapeutic targets and will potentially expand the array of novel therapies available for patients with this condition.
This educational activity is an archive of the live symposium held on October 31, 2025.
Target Audience
This educational activity is directed toward neuromuscular disease specialists, neurologists, specialty nurse practitioners, specialty physician assistants, nurses, and other health care providers involved in the care of patients with generalized myasthenia gravis.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Identify the role of B cells in the pathophysiology of gMG
- Evaluate clinical data for current and emerging B cell–directed therapies for gMG
- Develop treatment plans for patients with gMG
James F. Howard Jr, MD, FAAN
Professor of Neurology, Medicine, and Allied Health
UNC School of Medicine
The University of North Carolina at Chapel Hill
Chapel Hill, NC
Disclosures: Grant Research Support: Alexion Pharmaceuticals, Argenx, Biologix Pharma, Millennium Pharmaceuticals; Other: Alexion Pharmaceuticals, Argenx, Biologix Pharma
Katherine Ruzhansky, MD, MS
Director
Neuromuscular Division and EMG Lab
Medical University of South Carolina
Charleston, SC
Disclosures: Grant/Research Support: Immunovant, Janssen, UCB; Advisor, Consultant, Speaker, Honoraria Recipient: Alexion, Argenx, Immunovant, Janssen, UCB
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here